Eleven Biotherapeutics Inc (NASDAQ:EBIO)

1.91
Delayed Data
As of Apr 20
 +0.29 / +17.90%
Today’s Change
0.62
Today|||52-Week Range
2.01
+135.51%
Year-to-Date

Today’s Trading

Previous close1.62
Today’s open1.68
Day’s range1.63 - 1.91
Volume7,917,705
Average volume (3 months)1,723,703
Market cap$39.8M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2,155.56%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+2,928.38%
P/E ratioNM
Price/Sales1.38
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc-0.07-4.55%
NVUSNovus Therapeutics I...+0.17+3.63%
JAGXJaguar Health Inc-0.01-3.42%
RCKTRocket Pharmaceutica...+0.17+0.99%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)--
Annual revenue (last year)$30.0M
Annual profit (last year)$1.9M
Net profit margin6.31%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen Allen Hurly
Chief Financial Officer, Secretary &
Treasurer
Richard F. Fitzgerald
Corporate headquarters
Cambridge, Massachusetts

Forecasts